Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for DSGN stands at 50.429, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.168, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 52.083 and the Commodity Channel Index (CCI) at -36.308 further confirm a 0.16 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, DSGN is trading above its 60-day moving average of $9.843 and above its 200-day long-term moving average of $6.715. Key price levels to watch include the immediate resistance at $11.114 and strong support at $9.674. A break above $11.114 could signal a bull continuation, while falling below $9.674 may test the next Fibonacci floor at $8.967.

Design Therapeutics Inc (DSGN) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	8.234	8.967	9.674	10.407	11.114	11.847	12.554
Fibonacci	8.967	9.517	9.857	10.407	10.957	11.297	11.847

Design Therapeutics Inc (DSGN) Technical Indicators

2026-03-02

Name	Value
RSI_14	50.429
STOCHk_14_3_3	52.083
STOCHd_14_3_3	68.173
CCI_20	-36.308
AO_5_34	0.42
MOM_10	0.16
MACD_12_26_9	0.168

Design Therapeutics Inc (DSGN) Relative Strength Index (RSI) is 50.429, creating a Neutral signal.

Design Therapeutics Inc (DSGN) Stochastic Oscillator is 52.083, creating a Neutral signal.

Design Therapeutics Inc (DSGN) Stochastic RSI is 68.173, creating a Neutral signal.

Design Therapeutics Inc (DSGN) Commodity Channel Index (CCI) is -36.308, creating a Neutral signal.

Design Therapeutics Inc (DSGN) Awesome Oscillator is 0.42, creating a Buy signal.

Design Therapeutics Inc (DSGN) Momentum is 0.16, creating a Buy signal.

Design Therapeutics Inc (DSGN) MACD is 0.168, creating a Buy signal.

Design Therapeutics Inc (DSGN) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	10.584	Sell
MA_10	10.381	Sell
MA_20	10.295	Sell
MA_60	9.843	Buy
MA_200	6.715	Buy
MA_250	6.192	Buy

Design Therapeutics Inc (DSGN) 5-Day simple moving average is 10.584, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Sell.

Design Therapeutics Inc (DSGN) 10-Day simple moving average is 10.381, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Sell.

Design Therapeutics Inc (DSGN) 20-Day simple moving average is 10.295, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Sell.

Design Therapeutics Inc (DSGN) 60-Day simple moving average is 9.843, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Buy.

Design Therapeutics Inc (DSGN) 200-Day simple moving average is 6.715, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Buy.

Design Therapeutics Inc (DSGN) 250-Day simple moving average is 6.192, while Design Therapeutics Inc (DSGN) share price is $10.23, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for DSGN?

The overall technical consensus for Design Therapeutics Inc (DSGN) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 2 sell signals.

What are the key support and resistance levels for Design Therapeutics Inc (DSGN) today?

Based on pivot point calculations, Design Therapeutics Inc (DSGN) has an immediate support level at 9.674 and a major resistance level at 11.114. Traders also monitor the pivot point at 10.407 to determine the intraday trend direction.

Is Design Therapeutics Inc (DSGN) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Design Therapeutics Inc (DSGN) is currently 50.429. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Design Therapeutics Inc (DSGN)?

Design Therapeutics Inc (DSGN) Moving Averages Convergence Divergence (MACD) indicator is 0.168, suggesting DSGN is Neutral. This indicator helps identify potential trend reversals or momentum shifts for Design Therapeutics Inc.

How is Design Therapeutics Inc (DSGN) performing relative to its 200-day moving average?

Design Therapeutics Inc (DSGN) is currently trading at $10.23, which is above its 200-day simple moving average of 6.715. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

DSGN Technical

DSGN Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for DSGN